Drugs / Bovine Lipid Extract Surfactant
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04375735 | Nov 2020 → Sep 2021 | COVID-19, acute respiratory distress syndrome | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00312507 | Apr 2006 → ? | meconium aspiration syndrome | The Hospital for Sick Children | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04019106 Background | Oct 2019 → Oct 2020 | bronchopulmonary dysplasia, respiratory distress syndrome in premature infants | University of Manitoba | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01709409 Comparator | Mar 2013 → Aug 2016 | respiratory distress syndrome in premature infants | Ottawa Hospital Research Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bovine Lipid Extract Surfactant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00312507 ↗ |
| Known as | BLES | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01709409 ↗ |
| Route | Other | “given by endotracheal method” NCT01709409 ↗ |